For Parkinson's disease, Levodopa is the preferred treatment in the clinic.
However, long-term use of levodopa may lead to various motor complications, among which levodopa-induced dyskinesia is the most common, severely affecting patients' quality of life. Dr. Jiancheng He and co-workers from Shanghai University of Traditional Chinese Medicine in China established a model of Parkinson's disease dyskinesia in rats, and treated these animals with Compound Formula Rehmannia.
AdvertisementThey found that Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson's disease by modulating neurotransmitter signaling in the corpus striatum. The relevant article has been published in the Neural Regeneration Research (Vol. 9, No. 4, 2014).
PDeclining Intelligence in Old Age Linked to Visual Perception Speed Mutations in CTR9 Gene Could Play a Role in Development of Kidney Cancer in Children M
You May Also Like